- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
13 result(s) found for: Ecological study.
Displaying page 1 of 1.
| EudraCT Number: 2015-001752-30 | Sponsor Protocol Number: FoHM/Tonsillit2015 | Start Date*: 2015-07-03 |
| Sponsor Name:Public Health Agency of Sweden | ||
| Full Title: A randomised study of 5 and 10 days treatment with phenoxymethyl penicillin against streptococcal pharyngotonsillitis. | ||
| Medical condition: J03.0 Streptococcal pharyngotonsillitis | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-002604-41 | Sponsor Protocol Number: WP6-282512 | Start Date*: 2014-01-31 |
| Sponsor Name:University Medical Centre Utrech | ||
| Full Title: RGNOSIS: Ecological Effects of Decolonisation Strategies in Intensive Care | ||
| Medical condition: Colonisation and Infection with (multi drug resistant) Gram negative bacteria in ICU patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002406-12 | Sponsor Protocol Number: NL6220204217 | Start Date*: 2019-04-04 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A pragmatic single blind RCT of continuation versus discontinuation/ dose reduction of antipsychotic medicati... | ||
| Medical condition: HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose ... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-002039-32 | Sponsor Protocol Number: PlenadrEMA/1.1/2014 | Start Date*: 2014-09-02 | |||||||||||
| Sponsor Name:Rigshospitalet, Copenhagen University Hospital | |||||||||||||
| Full Title: PlenadrEMA study - Effect of modified-release compared to conventional hydrocortisone on fatigue, measured by Ecological Momentary Assessments; a pilot study to assess feasibility, responsiveness o... | |||||||||||||
| Medical condition: Secondary adrenal insufficiency due to hypopituitarism | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-003898-15 | Sponsor Protocol Number: FoHM/UVI2015 | Start Date*: 2015-12-07 |
| Sponsor Name:Public Health Agency of Sweden | ||
| Full Title: A randomized, controlled, multicentre trial of collateral damage on the intestinal microbiota inferred by cefotaxime versus temocillin in patients receiving empirical treatment for febrile urinary ... | ||
| Medical condition: Febrile urinary tract infection | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-000755-13 | Sponsor Protocol Number: DACLEAN | Start Date*: 2020-03-31 | |||||||||||
| Sponsor Name:CHU de Poitiers | |||||||||||||
| Full Title: ESTIMATION OF THE INCIDENCE OF COLONIZATION OF PERIPHERAL VENOUS CATHETERS AFTER SKIN DISINFECTION WITH 0.5% SODIUM HYPOCHLORITE, PRECEDED OR NOT BY AN APPLICATION OF 70% ETHANOL: PILOT, MONOCENTRI... | |||||||||||||
| Medical condition: Bacterial colonization of peripheral venous catheters | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-003251-37 | Sponsor Protocol Number: ACP-103-054 | Start Date*: 2019-06-11 | |||||||||||
| Sponsor Name:ACADIA Pharmaceuticals Inc | |||||||||||||
| Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate R... | |||||||||||||
| Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) SK (Prematurely Ended) PL (Prematurely Ended) FI (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2012-001104-37 | Sponsor Protocol Number: ME/2011/3709 | Start Date*: 2014-10-06 | ||||||||||||||||
| Sponsor Name:University Hospitals Bristol NHS Foundation Trust | ||||||||||||||||||
| Full Title: Pulsed glucocorticoid replacement therapy for patients with adrenocortical insufficiency secondary to Addison’s disease and congenital adrenal hyperplasia | ||||||||||||||||||
| Medical condition: Addison's disease and Congenital Adrenal Hyperplasia | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2021-001840-83 | Sponsor Protocol Number: SAGA | Start Date*: 2022-04-26 |
| Sponsor Name:University Medical Center Utrecht | ||
| Full Title: Short-course aminoglycosides as adjunctive treatment in adults with sepsis | ||
| Medical condition: Patients admitted with sepsis of unknown origin, suspected urinary origin or suspected abdominal origin | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-000574-26 | Sponsor Protocol Number: GH001-TRD-201 | Start Date*: 2022-11-25 | |||||||||||
| Sponsor Name:GH Research Ireland Limited | |||||||||||||
| Full Title: A randomized, double-blind, placebo-controlled, Phase 2b trial with an open-label extension to determine the safety and efficacy of GH001 in patients with treatment-resistant depression | |||||||||||||
| Medical condition: Treatment-resistant depression (TRD) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IE (Trial now transitioned) CZ (Trial now transitioned) PL (Trial now transitioned) ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-003487-36 | Sponsor Protocol Number: 1 | Start Date*: 2015-12-23 | |||||||||||
| Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust | |||||||||||||
| Full Title: Alternatives to prophylactic antibiotics for the treatment of recurrent urinary tract infection in women | |||||||||||||
| Medical condition: Recurrent urinary tract infection in women | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-002534-16 | Sponsor Protocol Number: FSJD-INNOVA-2020 | Start Date*: 2021-10-15 | |||||||||||
| Sponsor Name:Fundació Sant Joan de Déu | |||||||||||||
| Full Title: 12-month randomized, double-blind, placebo-controlled, pharmacological clinical trial to evaluate the effectiveness, cost-utility and neurobiological effects of low-dose Naltrexone in patients with... | |||||||||||||
| Medical condition: Fibromyalgia | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-023310-31 | Sponsor Protocol Number: MagicBullet/COLMER | Start Date*: 2011-02-07 | |||||||||||
| Sponsor Name:Consorcio de apoyo a la Investigación Biomédica en Red (CAIBER) | |||||||||||||
| Full Title: Ensayo clínico en fase IV aleatorizado, abierto, multicéntrico y de no inferioridad para comparar la seguridad y la eficacia de colistina iv. con meropenem iv. en el tratamiento de la neumonía asoc... | |||||||||||||
| Medical condition: Neumonía asociada a ventilación mecánica | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) IT (Completed) GR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.